Efficacy of the tissue press method for reducing systemic side effects of eye drops compared to nasolacrimal occlusio
Phase 4
Completed
- Conditions
- Adverse systemic effects of eye dropsEye - Diseases / disorders of the eye
- Registration Number
- ACTRN12616000404426
- Lead Sponsor
- uzia Mueller
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Participants must be 18 years old or more and be able to understand the purpose of this study and perform the interventions following Timolol application. Otherwise, all people, not fulfilling any of the exclusion criteria may be included. Informed consent has to be obtained.
Exclusion Criteria
-Health conditions that increase the probability of side effects of Timolol
-Hypersensitivity to Timolol or one of the additives
-Systemic Beta blocker intake
-Inability to understand and perform the instructions
-Pregnancy or ongoing breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method